ACI-35

N/A

Report date: 2024/06/28 10:19:34

Base Information

Drug NameACI-35
Drug Alias NameACI-35.030ACI-35JNJ-64042056JNJ-2056
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCognitive DysfunctionCognition DisordersTauopathies +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesSweden +[11] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAc Immune Sa
China Registration ClassN/A

Develop Information

Active CompaniesAc Immune SaJanssen Research & Development LlcJanssen Cilag N.V./S.A. +[4] 
Inactive CompaniesN/A
Active IndicationsCognitive DysfunctionCognition DisordersTauopathies +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A